Korean J Urol Oncol.  2017 Dec;15(3):131-136. 10.22465/kjuo.2017.15.3.131.

The Trend of Uro-Oncologist About Blood Test and Imaging Studies for the Diagnosis of Biochemical Recurrence in Korea

Affiliations
  • 1Department of Urology, Chungbuk National University Hospital, Cheongju, Korea. sjyun@chungbuk.ac.kr
  • 2Department of Urology, Chungbuk National University College of Medicine, Cheongju, Korea.
  • 3Department of Public Health and Preventive Medicine, Chungbuk National University Hospital, Cheongju, Korea.
  • 4Department of Preventive Medicine/Graduate School of Health Science Business Convergence, Chungbuk National University, Cheongju, Korea.

Abstract

PURPOSE
The aim of this study is to investigate the criteria of biochemical recurrence (BCR) and follow-up periods and methods with and without blood and imaging test of urologic oncology before established guidelines of prostate cancer in Korea.
MATERIALS AND METHODS
In December 2015, we sent the questionnaire to urologic oncologist in academic hospital and received the answer from 108 urologic oncologist (50%). Also, we analyzed the data of 1,141 patients underwent radical prostatectomy in 2005 from Korean Medical Insurance.
RESULTS
In follow-up, 72 physicians (66.7%) performed blood test every 3 months, 51 physicians (47.2%) performed imaging study in case of BCR. Bone scan was the most common imaging study in the follow-up (74 physicians, 68.5%). But, bone scan was only performed in case of BCR (43 physicians, 39.8%). The criteria of BCR was PSA 0.2 ng/mL (75 physician, 69.4%), 76 physicians (70.4%) was performed different follow-up according to risk of patients. In Korean Medical Insurance data analysis, PSA were performed average 2 times every year and magnetic resonance imaging, computed tomography, Bone scan were performed average 0.1, 0.2, 0.1 times every year, respectively.
CONCLUSIONS
The criteria of BCR and the follow-up of prostate cancer patients in Korea were similar Korean prostate cancer guidelines. Blood and imaging test might be increased compared to 10 years ago, it is necessary to compare the Korean Medical Insurance data between 10 years ago and present.

Keyword

Prostatic neoplasms; Recurrence; Prostate-specific antigen

MeSH Terms

Diagnosis*
Follow-Up Studies
Hematologic Tests*
Humans
Insurance
Korea*
Magnetic Resonance Imaging
Prostate-Specific Antigen
Prostatectomy
Prostatic Neoplasms
Recurrence*
Statistics as Topic
Prostate-Specific Antigen
Full Text Links
  • KJUO
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr